DB05124ExperimentalNucleic Acid Based Therapies
ARC183 is a DNA aptamer, which is a single-stranded DNA molecule consisting of 15 deoxynucleotides that forms well-defined three-dimensional configuration, allowing it to bind to thrombin with high affinity and... The key advantage of ARC183 compared to other thrombin inhibitors is its rapid onset of action and short half-life, giving it the potential to be an ideal agent for medical procedures that require rapid resolution...
- Primary indication
- Investigated for use/treatment in blood (blood forming organ disorders, unspecified), cardiac surgery, and coronary artery disease.Curator reviewed
- Code names
- ARC183
Which companies are running trials of ARC183, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account